Status:
UNKNOWN
The Benefits of Intensive Glycemic Control in Elderly Patients With Type 2 Diabetes
Lead Sponsor:
Taipei Veterans General Hospital, Taiwan
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
80+ years
Phase:
NA
Brief Summary
Aims/hypothesis: Populations worldwide are aging and type 2 diabetes is common in individuals aged \>80 years. The important issue that needs to be considered is whether tight glycemic control is ben...
Eligibility Criteria
Inclusion
- Men or women aged ≥80 years at time of randomization.There is no upper age limit.
- Be able to walk by themselves
- They had their first diagnosis of type 2 diabetes mellitus at age 30 years or older.
Exclusion
- Known advanced diabetic complications (such as proliferative retinopathy, chronic kidney disease stage IV or above).
- Overt clinical congestive heart failure (CHF) requiring treatment with a diuretic or ACE inhibitor.
- Previous documented cerebral or subarachnoid haemorrhage in the last 6 months
- Condition expected to severely limit survival
- Clinical diagnosis of dementia
- Resident in a nursing home
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
208 Patients enrolled
Trial Details
Trial ID
NCT00850798
Start Date
February 1 2009
End Date
December 1 2020
Last Update
July 26 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chen-Hsen Lee
Taipei, Taiwan, 11217